ACCESS IMMUNOASSAY SYSTEM RUBELLA IGG ASSAY

Enzyme Linked Immunoabsorbent Assay, Rubella

BECKMAN COULTER, INC.

The following data is part of a premarket notification filed by Beckman Coulter, Inc. with the FDA for Access Immunoassay System Rubella Igg Assay.

Pre-market Notification Details

Device IDK031606
510k NumberK031606
Device Name:ACCESS IMMUNOASSAY SYSTEM RUBELLA IGG ASSAY
ClassificationEnzyme Linked Immunoabsorbent Assay, Rubella
Applicant BECKMAN COULTER, INC. 1000 LAKE HAZELTINE DR. Chaska,  MN  55318 -1084
ContactLynn Weist
CorrespondentLynn Weist
BECKMAN COULTER, INC. 1000 LAKE HAZELTINE DR. Chaska,  MN  55318 -1084
Product CodeLFX  
CFR Regulation Number866.3510 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2003-05-22
Decision Date2003-06-20
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.